1,809 results match your criteria Annales D Urologie[Journal]


Prostate cancer at the 2007 ASCO meeting: an urologist's perspective.

Authors:
N Mottet

Ann Urol (Paris) 2007 Nov;41 Suppl 5:S105-18

Département d'Urologie, Clinique Mutualiste, 3, rue Le Verrier, 42100 Saint-Etienne, France.

During the last ASCO meeting in Chicago, multiple presentations focused on prostate cancer. Several prognostic factors have been developed, either at the initial stage or early during treatment. At the localized stage, the change in prostate volume, evaluated using MRI after 2 months of hormone therapy, is a strong predictor of recurrence following the combination of radiotherapy with hormone therapy. Read More

View Article and Full-Text PDF
November 2007

[Surgical treatment of ureteropyelic junction stenosis using robotic-assisted laparoscopy].

Authors:
C Egrot J Hubert

Ann Urol (Paris) 2007 Dec;41(6):306-14

Service d'urologie, Centre hospitalier universitaire de Nancy-Brabois, 5, rue du Morvan, 54511 Vandoeuvre-les-Nancy, France.

Since the introduction of mini-invasive surgery approximately thirty years ago, Laparoscopic surgery has significantly evolved both in terms of its extended field of application and of the tools used which were diversified and improved. More recently, the development of robotic-assisted laparoscopy has brought, among other improvements, three-dimensional vision, dexterity, and a comfortable working position, which have reduced the surgeon's fatigability, the difficulties related to the operations and the learning curves of standard laparoscopy. Urology, which makes slightly less use of standard laparoscopy than general or gynaecological surgery, largely benefits from robotics concerning the precision of movements, and has much increased the operating indications of laparoscopy, including the treatment of pyeloureteral junction, kidney tumourectomy, living donor nephrectomy and radical prostactectomy. Read More

View Article and Full-Text PDF
December 2007

[Robotic-assisted laparoscopy: general principles].

Authors:
J Hubert

Ann Urol (Paris) 2007 Dec;41(6):298-305

Service d'urologie, Centre hospitalier universitaire de Nancy-Brabois, 5 rue du Morvan, 54511 Vandoeuvre-lès-Nancy, France.

Born in the late 90s, robotic-assisted laparoscopy has today an exponential growth. It presents some disadvantages, the first of them being a very high cost, similarly to all new medical technologies. On the other hand, its advantages are very important and allow the open surgeon to apply his natural skills to the endoscopic approach, while recovering the 3-dimensional vision. Read More

View Article and Full-Text PDF
December 2007

[De novo tumours of renal transplants].

Ann Urol (Paris) 2007 Dec;41(6):285-97

Service de chirurgie urologique, clinique Jules Verne, 2-4, route de Paris, 44314 Nantes cedex 3, France.

Kidney cancer occurs rarely and late in renal transplants. The lack of grafts and the increasing age of the cadaver donors are likely to result in an increasing number of such cancers. To date, the treatment of choice is the transplant removal. Read More

View Article and Full-Text PDF
December 2007

[Immunosuppression in kidney transplantation].

Ann Urol (Paris) 2007 Dec;41(6):276-84

Service de transplantation rénale adulte, Hôpital Necker, 149, rue de Sèvres, 75015 Paris, France.

Kidney transplantation has become the treatment of choice in end-stage chronic renal failure since it significantly improves both the quality of life and the life duration of affected patients, when compared with dialysis. Some of these better results that were observed over the last thirty years are obviously due to significant improvements in the quality of immunosuppression. In the first part of this chapter, the allo-immune response is schematically described regarding the various signals. Read More

View Article and Full-Text PDF
December 2007

[Surgical complications in kidney transplantation].

Ann Urol (Paris) 2007 Dec;41(6):261-75

Clinique urologique, Hôpital Hôtel-Dieu, place Alexis-Ricordeau, 44093 Nantes cedex, France.

Kidney transplantation has become the treatment of choice for patients with end stage renal disease since it offers an excellent quality of life. Moreover, the economic impact is considerable, particularly beyond the first year. Indeed, the annual cost of a successful renal transplantation is ten fold lower than haemodialysis. Read More

View Article and Full-Text PDF
December 2007

[Prostate cancer, the urologist, the patient, and treatment].

Authors:
A Bouregba T Lebret

Ann Urol (Paris) 2007 Oct;41 Suppl 3:S87-91

Psychologue conseil à la ligue nationale contre le cancer où il intervient dans des groupes de parole de patients ayant un cancer de la prostate.

Prostate cancer, particularly advanced prostate cancer, should be considered as a chronic disease that requires multidisciplinary management. Each health professional involved the urologist of course, but also the other therapists, especially the general practitioner and nurse, should place their activities within a therapeutic synergy. The onco-psychological dimension should not be underestimated. Read More

View Article and Full-Text PDF
October 2007

[Contribution of LHRH analogs in prostate cancer treatment].

Authors:
M Zerbib

Ann Urol (Paris) 2007 Oct;41 Suppl 3:S83-6

Service d'urologie, hôpital Cochin, 27, rue du Faubourg Saint-Jacques, 75014 Paris, France.

The contribution of LHRH analogs is enormous in prostate cancer management at nearly all stages of the disease, the Leading cancer in males over 50 years of age. They make it possible to use hormone therapy reliably, with Little morbidity, and can be reversed. Their use can be immediate or delayed, continuous or intermittent, whether or not they are associated with an antiandrogen, and can be associated with chemotherapy for patients who have reached the stage of hormone-refractory prostate cancer. Read More

View Article and Full-Text PDF
October 2007

[Evidence-based medicine in urology].

Authors:
J F Bergmann

Ann Urol (Paris) 2007 Oct;41 Suppl 3:S80-2

Service de médecine interne A, hôpital Lariboisière, 2, rue Ambroise-Paré 75475 Paris Cedex 10, France.

The quality of a therapeutic trial depends on several parameters. The ideal trial in prostate cancer should be a high-quality trial on a well-defined and significant population. The method used to calculate the number of subjects necessary should appear in the study. Read More

View Article and Full-Text PDF
October 2007

[Prostate cancer: future strategies for chemotherapy management].

Authors:
K Fizazi

Ann Urol (Paris) 2007 Oct;41 Suppl 3:S77-9

Institut Gustave-Roussy, 14, avenue Paul-Vaillant-Couturier, 94800 Villejuif, France.

Chemotherapy is one the therapeutic options in prostate cancer. Docetaxel once every three weeks is the current standard for castration-refractory disease with cancer-related symptoms. The docetaxel plus estramustine association is likely more active than docetaxel alone. Read More

View Article and Full-Text PDF
October 2007

[Management of rising PSA after total prostatectomy].

Authors:
M Zerbib

Ann Urol (Paris) 2007 Oct;41 Suppl 3:S73-6

Service d'urologie, hôpital Cochin, 27, rue du Faubourg Saint-Jacques, 75014 Paris, France.

Rising PSA after radical prostatectomy corresponds to a biochemical recurrence, i.e., a new rise in PSA levels. Read More

View Article and Full-Text PDF
October 2007

[Adjuvant treatment after total prostatectomy].

Authors:
P Richaud

Ann Urol (Paris) 2007 Oct;41 Suppl 3:S69-72

Institut Bergonié, 229, cours de l'Argonne, 33076 Bordeaux, France.

Several adjuvant treatments are used after radical prostatectomy. In case of local risk of recurrence, adjuvant radiotherapy decreases the risk of biochemical recurrence but does not improve the overall survival. In case of metastasis risk, adjuvant hormone therapy should be discussed. Read More

View Article and Full-Text PDF
October 2007

[Oncological and functional results of total prostatectomy: an objective open analysis versus laparoscopy].

Authors:
J D Doublet

Ann Urol (Paris) 2007 Oct;41 Suppl 3:S64-8

Service d'urologie, hôpital Tenon, 4, rue de la Chine, 75020 Paris, France.

Based on a systematized literature analysis, laparoscopic radical prostatectomy is associated with less peroperative blood loss than open surgery. Operative time is shorter using an open approach. In terms of cancer control and functional results, no difference was found between both approaches. Read More

View Article and Full-Text PDF
October 2007

[The contribution of imaging before, during, and after prostatectomy].

Authors:
P Younes

Ann Urol (Paris) 2007 Oct;41 Suppl 3:S59-63

Département de radiologie, hôpital Cochin, 27, rue du Faubourg Saint-Jacques, 75014 Paris, France.

Before prostatectomy, imaging has a dual role: detecting cancer and staging it. During prostatectomy, imaging can guide the surgeon by localizing a probable zone of prostate extension that therefore contraindicates vessel and nerve preservation. After la prostatectomy, imaging can be useful to differentiate local recurrence and distant metastasis. Read More

View Article and Full-Text PDF
October 2007

[Contribution of pathological anatomy before and after total prostatectomy].

Authors:
V Molinié

Ann Urol (Paris) 2007 Oct;41 Suppl 3:S51-8

Service de pathologie, hôpital Saint-Joseph, 185, rue Raymond-Losserand, 75674 Paris cedex 14, France.

Before radical prostatectomy, the pathologist analyzes the prostate biopsies. He has to affirm the diagnosis of cancer when present, and to provide prognosis parameters such as the Gleason score, the percentage of tumor, and to report an extraprostatic extension when present. After the radical prostatectomy, the pathologist has to analyze the surgical specimen. Read More

View Article and Full-Text PDF
October 2007

[Surgical treatment of ureteral stenosis after kidney transplantation].

Authors:
E Rolland B Barrou

Ann Urol (Paris) 2007 Oct;41(5):254-9

Service d'urologie et de transplantation rénale et pancréatique, Groupe hospitalier Pitié-Salpêtriére, 47-83, boulevard de l'Hôpital, 75013 Paris, France.

Ureteral stenosis is the most frequent complication after kidney transplantation. The diagnosis is based on an elevated creatinine level and a dilatation of the urinary cavity. The first step of the management is a urinary diversion with endo-ureteral prosthesis or a nephrostomy placement. Read More

View Article and Full-Text PDF
October 2007

[Indications, techniques and outcomes of high-intensity focused ultrasound (HIFU) for the treatment of localized prostate cancer].

Ann Urol (Paris) 2007 Oct;41(5):237-53

Hôpital edouard Herriot, 5, place d'Arsonval, 69437 Lyon 03, France.

High-intensity focused ultrasound (HIFU) is a minimally invasive alternative for patients with localized prostate cancer, not suitable for radical prostatectomy because of a life expectancy less than 10 years or because of major co-morbidities precluding surgery. HIFU can be performed in patients with LUTS (associated TURP) or with a previous history of BPH surgery. HIFU is repeatable after the initial procedure if a recurrent cancer is diagnosed on control biopsies. Read More

View Article and Full-Text PDF
October 2007

[Metabolic aspects of bowel use in urologic surgery].

Authors:
R de Petriconi

Ann Urol (Paris) 2007 Oct;41(5):216-36

Urologische Klinik und Poliklinik der Universität Ulm, Prittwitzstr. 42-43, D 89075 Ulm, Allemagne.

Urinary diversion, pouches and orthotopic bladder replacement have been made possible by the use of bowel segments in urologic surgery. The most important complications at short and long-term are metabolic disorders due to the permanent contact of urine with the bowel segment or the exclusion of this segment from bowel continuity. Metabolic acid-base problems occur immediately after the derivation beginning and depend on the renal capacity to compensating. Read More

View Article and Full-Text PDF
October 2007

[Urachal diseases].

Authors:
A Descazeaud

Ann Urol (Paris) 2007 Oct;41(5):209-15

Service d'urologie, Hôpital Cochin, 27, rue du Faubourg St-Jacques, 75014 Paris, France.

Urachal diseases are infrequent. Congenital affections include cysts, fistula, diverticulum, external sinus, and alternating drainage sinus. Ultrasonography and fistulography are useful for the diagnosis. Read More

View Article and Full-Text PDF
October 2007

[Surgical treatment of urethral stenoses: technical aspects].

Ann Urol (Paris) 2007 Aug;41(4):173-207

Département d'urologie, Hôpital universitaire de Gand, De Pintelaan 185, 9000 Gand, Belgique.

This article is an extensive review on open surgery techniques for urethral strictures from the membranous urethra after pelvic fracture up to the meatus urethrae. It is based on more than 10 year personal experience with nearly all mentioned techniques and a PubMed review on the subject from 1992 to 2005. Most of the studies published are descriptive and retrospective and deliver only a level 3 of evidence. Read More

View Article and Full-Text PDF

[Laparoscopic nephrectomy in a living donor].

Authors:
A Feifer M Anidjar

Ann Urol (Paris) 2007 Aug;41(4):158-72

McGill University Health Center, Royal Victoria Hospital, Department of urology, S6.88 Pine Avenue West, Montréal, Québec, Canada.

Kidney transplantation is the therapeutic option of choice for patients with end-stage renal disease. With the advent of safer harvesting techniques and immunosuppression, both donor and recipient outcomes have markedly improved in recent years. Kidney donation from Living donors remains the single most important factor responsible for improving patient and graft survival. Read More

View Article and Full-Text PDF

[Prostate MRI spectroscopy].

Ann Urol (Paris) 2007 Aug;41(4):145-57

Centre médicochirurgical Paris V, service d'imagerie médicale, 36, boulevard Saint-Marcel, 75005 Paris, France.

MRI spectroscopy is a non invasive method for detecting active metabolites used as markers. Chorine and citrate are used for analyzing prostate cancer. MRI spectroscopy combines morphologic imaging and metabolic cartography. Read More

View Article and Full-Text PDF

[Laparoscopic approach in partial nephrectomy].

Ann Urol (Paris) 2007 Jun;41(3):134-44

Service d'urologie, Centre hospitalier universitaire Henri Mondor, 51, avenue du Markchal-De-Lattre-De-Tassigny, 94000 Créteil, France.

Except for segmental parenchymal atrophies, partial nephrectomy is more and more often indicated when treating isolated small renal tumours. During the last few years this technique has been increasingly accepted for the excision of tumours less than 4 centimetres. In order to diminish the operative morbidity, the laparoscopic approach has been proposed. Read More

View Article and Full-Text PDF

[Male infertility: definition and pathophysiology].

Ann Urol (Paris) 2007 Jun;41(3):127-33

Service d'urologie et d'andrologie, Hôpital Robert Debré, avenue du Général-Koenig, 51092 Reims cedex, France.

Male infertility is present in 50% of couple infertility. Diagnosis of infertility requires methodical and rigorous approach based upon knowledge of the pathophysiology and the causes of infertility. Read More

View Article and Full-Text PDF

[What about lombo-aortic curage in the treatment of testicle cancer?].

Ann Urol (Paris) 2007 Jun;41(3):116-26

Service d'urologie, CHU Lapeyronie, 34000 Montpellier, France.

The indications and techniques of retroperitoneal lymphadenectomy in stage I non seminomatous germ cell tumours have markedly evolved over the past ten years. A literature review allows noticing that historical radical retroperitoneal dissection has been replaced by more limited techniques, known as nerve sparing and nerve preserving lymph node dissection. Stage I non seminomatous germ cell tumours are classified according to the risk of retroperitoneat lymph node involvement; they constitute three groups: low, intermediate and high risk tumours. Read More

View Article and Full-Text PDF

[Artificial neural networks for decision making in urologic oncology].

Authors:
M Remzi B Djavan

Ann Urol (Paris) 2007 Jun;41(3):110-5

Service d'urologie, Université médicale de Vienne, Währinger Gürtel 18-20, 1090 Vienne, Autriche.

This chapter presents a detailed introduction regarding Artificial Neural Networks (ANNs) and their contribution to modern Urologic Oncology. It includes a description of ANNs methodology and points out the differences between Artifical Intelligence and traditional statistic models in terms of usefulness for patients and clinicians, and its advantages over current statistical analysis. Read More

View Article and Full-Text PDF

[Is hysterectomy indicated during prolapsus treatment?].

Ann Urol (Paris) 2007 Jun;41(3):91-109

Maternité Hôtel-Dieu, Unité d'urogynécologie, Centre hospitalier universitaire, boulevard Léon-Malfrey, 63003 Clermont-Ferrand cedex, France.

Hysterectomy remains a usual procedure in vaginal reconstructive pelvic surgery. However, it may seem illogical, given our improved knowledge of the pathologic pelvic anatomy, to begin pelvic repair by a removal procedure. The question about uterine preservation during vaginal reconstructive surgery is crucial. Read More

View Article and Full-Text PDF

[Laparoscopic hysterectomy: technique, indications].

Ann Urol (Paris) 2007 Apr;41(2):80-90

IRCAD/EITS, 1, place de l'Hôpital, B.P. 426, 67091 Strasbourg, France.

Today, hysterectomy is, after caesarean section, the most frequent surgical intervention performed in fertile women. Introduced in 1989, laparoscopic hysterectomy remains poorly diffused: today, less than 5% of all hysterectomies remain done by laparoscopy. Nevertheless after a correct learning curve, laparoscopic hysterectomy finds perfect indications in benign and even some malignant indications. Read More

View Article and Full-Text PDF

[Techniques, indications and results of permanent prostate brachytherapy for localized prostate cancer].

Ann Urol (Paris) 2007 Apr;41(2):68-79

Service d'urologie, hôpital Salvator, 249, boulevard de Sainte-Marguerite, BP51, 13274 Marseille, France.

Permanent seed brachytherapy as a monotherapy is an appropriate treatment in patients with low risk localized prostate cancer such as intraprostatic cancer, T1-2 stage, PSA less than 10 ng/mL, low tumour volume, well differentiated cancer (Gleason score less than 7), gland size less than 50 mL, no micturition symptoms that could decompensate after implantation. A brachytherapy program needs a specialized multidisciplinary team with the collaboration of urologists, radiotherapists (authorized person to manipulate radioactive elements), and physicists. The 10-year oncologic and morbidity results have been published in the literature and are comparable to those of other standard treatments of localized prostate cancer such as radical prostatectomy and external beam radiation therapy. Read More

View Article and Full-Text PDF

[Testis germ cell tumours: which chemotherapy, for which patients?].

Authors:
A Fléchon J P Droz

Ann Urol (Paris) 2007 Apr;41(2):56-67

Département de cancérologie médicale, Centre Lóon-Bérard, 28, rue Laënnec, 69008 Lyon, France.

Germ cell tumours of the testis are curable disease. Two different pathological subtypes are observed: seminoma and non-seminoma. Two tumour stages have been defined: the disease limited to the testis and the advanced disease. Read More

View Article and Full-Text PDF